*Update, 13 December, 11:45 a.m.: A third laboratory at the National Institutes of Health (NIH) is also affected by the agency’s temporary ban on acquiring new human fetal tissue, an agency spokesperson confirmed last night. Initially, NIH said only research projects run by staff scientists at the National Eye Institute (NEI) and the National Institute of Allergy and Infectious Diseases (NIAID) would be affected. The third laboratory is at the National Cancer Institute (NCI), which is pursuing a “project on cancer immunotherapy, which will need tissue by January 31,” the agency said in a statement. “We are determining appropriate next steps to obtain tissue so that the NIAID project can begin and to avoid interruption of the NCI project. NEI does not have an immediate need to procure new fetal tissue (they have frozen stores).”
Here is our story from 7 December:
U.S. President Donald Trump’s administration has ordered scientists employed by the U.S. National Institutes of Health (NIH) to stop acquiring new human fetal tissue for experiments, ScienceInsider has learned. The suspension, imposed this past September without a public announcement, came as the government launched a review of all fetal tissue research funded by the federal government. The pause affects two laboratories run by the Bethesda, Maryland–based agency, NIH officials say. In one case, it disrupted a study probing how the virus that causes AIDS initially colonizes human tissues.